Triel-sur-Seine, France

Albert Lenaers


Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 42(Granted Patents)


Location History:

  • Triel sur Seine, BE (1993)
  • Triel Sur Seine, FR (1992 - 1997)

Company Filing History:


Years Active: 1992-1997

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Albert Lenaers

Introduction

Albert Lenaers is a notable inventor based in Triel-sur-Seine, France. He has made significant contributions to the field of medicinal chemistry, holding a total of seven patents. His work focuses on the development of new compounds that can be utilized therapeutically.

Latest Patents

Among his latest patents are the substituted phenoxyisobutyric acids and esters. These new compounds can be used as medicaments and correspond to a specific chemical formula. The compounds, along with their physiologically tolerable salts, have potential therapeutic applications. This innovation highlights Lenaers' commitment to advancing medical science through his research.

Career Highlights

Albert Lenaers is associated with Adir Et Compagnie, where he continues to develop his innovative ideas. His career is marked by a dedication to creating effective medicinal compounds that can improve health outcomes. His expertise in chemistry and pharmacology has positioned him as a valuable contributor to his field.

Collaborations

Lenaers has worked alongside notable colleagues such as Jean-Paul Vilaine and Gilbert Regnier. Their collaborative efforts have further enhanced the research and development of new medicinal compounds.

Conclusion

Albert Lenaers exemplifies the spirit of innovation in the field of medicinal chemistry. His patents and collaborative work contribute significantly to the advancement of therapeutic solutions. His ongoing research continues to inspire future developments in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…